Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
COCH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CENPV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LBH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD74 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LDOC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIMS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LY9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPVL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00960 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CELSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPCAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM174B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAPTM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM101B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA2022 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on